medigraphic.com
ISSN 1561-302X (Print)

2022, Number 1

<< Back Next >>

Rev cubana med 2022; 61 (1)

Frequency of pulmonary hypertension in patients with chronic obstructive pulmonary disease

Toquica SNE, Sarduy PM, Oramas DM, Hechavarría PS

Language: Spanish
References: 30
Page: 1-15
PDF size: 454.28 Kb.


ABSTRACT

Introduction: Chronic obstructive pulmonary disease is one of the most frequent, worldwide. It has impact on mortality, causing significant disability and affecting a considerable number of subjects of productive age. Pulmonary hypertension is a common complication of chronic respiratory diseases, particularly chronic obstructive pulmonary disease.
Objective: To describe patients with chronic obstructive pulmonary disease and suspected pulmonary hypertension.
Methods: A descriptive, prospective study was carried out in 50 patients treated at Benéfico Jurídico Pneumological Hospital from November 2016 to January 2018. Variables such as age, sex, ventilatory function test, chest X-ray, electrocardiogram and the echocardiogram were analyzed.
Results: Out of 700 patients with chronic lung disease, pulmonary hypertension was suspected in 7% and confirmed in 34. The frequencies by sex were similar and those older than 60 years prevailed. 41.6% of the patients had severe respiratory involvement, 70.6% had mild pulmonary hypertension and 64.7% had grade 3 dyspnea. The kappa indices between the techniques used for the diagnosis of pulmonary hypertension exceeded the figure of 0.74.
Conclusions: The frequency of pulmonary hypertension in patients with chronic obstructive pulmonary disease was high. Patients with severe impairment of respiratory function and mild pulmonary hypertension predominated. The degree of chronic obstructive pulmonary disease did not determine the severity of pulmonary hypertension. The highest concordance values between diagnostic techniques were obtained for radiography and echocardiography.


REFERENCES

  1. Burney P, Jarvis D, Perez Padilla R. The global burden of chronic respiratory disease in adults. Int J Tuberc Lung Dis. 2015;19:10-20. DOI: https://doi.org/10.5588/ijtld.14.0446

  2. Organización Mundial de la salud (OMS). Enfermedad pulmonar obstructiva crónica (EPOC). Nota descriptiva. 2016[acceso: 23/02/2021]. Disponible en: http://www.who.int/mediacentre/factsheets/fs315/es/

  3. GBD 2015 Disease and injury incidence and prevalence collaborators. Global, regional, and national incidence, prevalence, and years lived with disability for 310 diseases and injuries, 1990-2015: a systematic analysis for the Global Burden of Disease Study 2015. Lancet. 2016;388(10053):1545-602. DOI: https://doi.org/10.1016/S0140-6736(16)31678-6

  4. Grigsby M, Siddharthan T, Chowdhury MA, Siddiquee A, Rubinstein A, Sobrino E, et al. Socioeconomic status and COPD among low- and middle-income countries. Int J Chron Obstruct Pulmon Dis. 2016;11:2497-507. DOI: https://doi.org/10.2147/COPD.S111145

  5. Martinez CH, Mannino DM, Jaimes FA, Curtis JL, Han MK, Hansel NN, et al. Undiagnosed obstructive lung disease in the United States. Associated factors and long-term mortality. Ann Am Thorac Soc. 2015;12:1788-95. DOI: https://doi.org/10.1513/AnnalsATS.201506-388OC

  6. Parron Collar D, Pazos Guerra M, Rodríguez P, Gotera C, Mahíllo-Fernández I, Peces-Barba G, et al. COPD is commonly underdiagnosed in patients with lung cancer: Results from the RECOIL study (retrospective study of copd infradiagnosis in lung cancer). Int J Chron Obstruct Pulmon Dis. 2017;12:1033-8. DOI: https://doi.org/10.2147/COPD.S123426

  7. Kaplan A, Thomas M. Screening for COPD: The gap between logic and evidence. Eur Respir Rev. 2017;26(143):1601-13. DOI: https://doi.org/10.1183/16000617.0113-2016

  8. Menezes AM, Pérez Padilla R, Jardim JR, Muiño A, López MV, Valdivia G, et al. Chronic obstructive pulmonary disease in five Latin American cities (The PLA-TINO Study): A prevalence study. Lancet. 2005;366:1875-81. DOI: https://doi.org/10.1016/S0140-6736(05)67632-5

  9. Caballero A, Torres Duque CA, Jaramillo C, Bolívar F, Sanabria F, Osorio P, et al. Prevalence of COPD in five Colombian cities situated at low, medium, and high altitude (PREPOCOL study). Chest. 2008;133:343-9. DOI: https://doi.org/10.1378/chest.07-1361

  10. Jaganath D, Miranda JJ, Gilman RH, Wise RA, Diette GB, Miele CH, et al. Cronicas cohort study group. Prevalence of chronic obstructive pulmonary disease and variation in risk factors across four geographically diverse resource-limited settings in Peru. Respir Res. 2015;16:40. DOI: https://doi.org/10.1186/s12931-015-0198-2

  11. Park SK, Larson JL. Metabolic syndrome and associated factors in people with chronic obstructive pulmonary disease. West J Nurs Res. 2014;36:620-42. DOI: https://doi.org/10.1177/0193945913512423

  12. Breyer MK, Spruit MA, Hanson CK, Franssen FM, Vanfleteren LE, Groenen MT, et al. Prevalence of metabolic syndrome in COPD patients and its consequences. PLoS One. 2014;9:e98013. DOI: https://doi.org/10.1371/journal.pone.0098013

  13. Hankinson JL, Odencrantz JR, Fedan KB. Spirometric reference values from a sample of the general U.S. population. Am J Respir Crit Care Med. 1999;159:179-87. DOI: https://doi.org/10.1164/ajrccm.159.1.9712108

  14. Beasley R, Calverley P, Casanova C, Donohue J, Hanania N, Montes de Oca M, et al. Global Initiative for Chronic Obstructive Lung Disease. Estrategia global para el diagnóstico, manejo y prevención de la EPOC. 2017[acceso: 23/02/2021]. Disponible en: https://goldcopd.org/wp-content/uploads/2016/04/wms-spanish-Pocket-Guide-GOLD-2017.pdf

  15. Barberà JA, Román A, Gómez Sánchez M.A, Blanco I, Otero R, López Reyes R, et al. Diagnóstico y tratamiento de la hipertensión pulmonar. Respira-Fundación Española del Pulmón-Sociedad Española de Neumología y Cirugía Torácica (SEPAR). Eur Respir J. 2017;46:903-75. DOI: http://dx.doi.org/10.1183/13993003.01032-2015

  16. Simonneau G, Gatzoulis MA, Adatia I, Celermajer D, Denton C, Ghofrani A, et al. Updated clinical classification of pulmonary hypertension. J Am Coll Cardiol. 2013;62:34-41. DOI: http://dx.doi.org/10.1016/j.jacc.2013.10.029

  17. Salisbury JP, Grignola JC, Pascal G, Domingo E, Parma G, Trujillo P, et al. Hipertensión pulmonar en la EPOC: puesta al día. Rev Urug Cardiol. 2013[acceso: 22/05/2018];28(2):163-76. Disponible en: http://www.scielo.edu.uy/scielo.php?script=sci_arttext&pid=S1688-04202013000200008&lng=es

  18. Galie N, Humbert M, Vachiery JL, Gibbs S, Lang I, Torbicki A, et al. 2015 ESC/ERS Guidelines for the diagnosis and treatment of pulmonary hypertension: The Joint Task Force for the Diagnosis and Treatment of Pulmonary Hypertension of the European Society of Cardiology (ESC) and the European Respiratory Society (ERS): Endorsed by: Association for European Paediatric and Congenital Cardiology (AEPC), International Society for Heart and Lung Transplantation (ISHLT). Eur Heart J. 2016;37:67-119. DOI: http://dx.doi.org/10.1093/eurheartj/ehv317

  19. Escribano Subias P, Blanco I, López Meseguer M, López Guarch CJ, Roman A, Morales P, et al. Survival in pulmonary hypertension in Spain: insights from the Spanish regis-try. Eur Respir J. 2012;40: 596-603. DOI: http://dx.doi.org/10.1183/09031936.00101211

  20. Bolaños Campos I. Hipertensión arterial pulmonar, Guías de manejo. Rev Costarric Cardiol. 2012;14(1-2):26-54. DOI: https://hdl.handle.net/20.500.11764/81

  21. Bossone E, D'Andrea A, D'Alto M, Citro R, Argiento P, Ferrara F, et al. Echocardiography in pulmonary arterial hypertension: from diagnosis to prognosis. J Am Soc Echocardiogr. 2013;26:1-14. DOI: https://doi.org/j.echo.2012.10.009

  22. Portillo K, Torralba Y, Blanco I, Burgos F, Rodríguez Roisin R, Ríos J, et al. Pulmonary hemodynamic profile in chronic obstructive pulmonary disease. Int J Chron Obstruct Pulm Dis. 2015;10:1313. DOI: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4507485/

  23. Seeger W, Adir Y, Barberà JA, Champion H, Coghlan JG, Cottin V, et al. Pulmonary hypertension in chronic lung diseases. J Am Coll Cardiol. 2013;62(25 Suppl):109-16. DOI: https://www.ncbi.nlm.nih.gov/pubmed/24355635

  24. Hoeper MM, Marc Humbert M, Souza R. Perspectiva general de la hipertensión pulmonar. Lancet Respir Med. 2016;4:306-22. DOI: https://doi.org/10.1016/S2213-2600(15)00543-3

  25. Chaouat A, Bugnet AS, Kadaoui N, Schott R, Enache I, Ducoloné A, et al. Severe pulmonary hypertension and chronic obstructive pulmonary disease. Am J Resp Crit Care Med. 2005;172(2):189-94. DOI: https://doi.org/10.1164/rccm.200401-006OC

  26. Regard L, Montani D. Hipertensión arterial pulmonar. EMC-Tratado de medicina. 2017;22(1):1-11. DOI: http://dx.doi.org/10.1016/S1636-5410(17)87874-0

  27. Barbero MA. EPOC e hipertensión pulmonar. Arch Bronconeumol. 2009;45(Supl 4):24-30. DOI: https://doi.org/10.1016/S0300-2896(09)72860-1

  28. Cadenas S, Martín J, Álvarez P, González D, Oterino A, Escribano P, et al. Hipertensión pulmonar (I). Hipertensión arterial pulmonar. Medicine. 2017;12(45):2655-73. DOI: https://doi.org/10.1016/j.med.2017.11.003

  29. Thabut G, Dauriat G, Stern JB, Logear D, Levy A, Marrash Chahla R, et al. Pulmonary hemodynamics in advanced COPD candidates for lung volume reduction surgery or lung transplantation. Chest. 2005;127:1531-6. DOI: https://doi.org/10.1378/chest.127.5.1531

  30. Ordoñez Vázquez AL, Montes Castillo C, Mora Soto JR, Sánchez Hernández JD. Hipertensión arterial pulmonar. Residente. 2015[acceso: 23/02/2021];10(1):18-30. Disponible en: www.medigarphic.com/elresidente




2020     |     www.medigraphic.com